Irbesartan-Mepha 150 mg, Filmtabletten - 98 Tablette(n) Swissmedic Key 61511002 Registration Holder Mepha Pharma AG Name Irbesartan-Mepha 150 mg, Filmtabletten Date of registration 09.02.2011 Original/Generic Generic Introduction of Sequence 09.02.2011 ATC-Classification Irbesartan (C09CA04) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 02.07.10. Show package size 98 Tablette(n) Index Therapeuticus (Swissmedic) 02.07.10. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 39.79 Limitation No Deductible 10 % Consumer price 59.70 Feedback FB Daily cost GTIN 7680615110023 Medication Code Synthetika Pharmacode 5326025 Disponibility
Composition irbesartanum 150.0 mg, povidonum K 30, amylum pregelificatum, poloxamerum 188, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.64 mg, silica colloidalis hydrica, magnesii stearas, Überzug: polydextrosum, E 171, hypromellosum, macrogolum 4000, pro compresso obducto. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Irbesartan 150 mg
BAG: Active Agent Dose Irbesartan 150 mg
Inactive agents Dose additional_information Amylum Pregelificatum Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. Hypromellosum Macrogol 4000 Magnesii Stearas Poloxamer 188 Polydextrosum Überzug Povidonum K 30 Pro Compresso Obducto Silica Colloidalis Hydrica
Source Data was imported : 12.05.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
